Search Results - "Sarkar, Surajit"

Refine Results
  1. 1

    Tissue-Specific Upregulation of Drosophila Insulin Receptor (InR) Mitigates Poly(Q)-Mediated Neurotoxicity by Restoration of Cellular Transcription Machinery by Raj, Kritika, Sarkar, Surajit

    Published in Molecular neurobiology (01-02-2019)
    “…Polyglutamine [poly(Q)] disorders are a class of trinucleotide repeat expansion neurodegenerative disorders which are dominantly inherited and progressively…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Transactivation Domain of Human c-Myc Is Essential to Alleviate Poly(Q)-Mediated Neurotoxicity in Drosophila Disease Models by Raj, Kritika, Sarkar, Surajit

    Published in Journal of molecular neuroscience (01-05-2017)
    “…Polyglutamine (poly(Q)) disorders, such as Huntington’s disease (HD) and spinocerebellar ataxias, represent a group of neurological disorders which arise due…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Noncytotoxic WORM Memory Using Lysozyme with Ultrahigh Stability for Transient and Sustainable Electronics Applications by Banik, Hritinava, Sarkar, Surajit, Bhattacharjee, Debajyoti, Malhotra, Akshit, Chauhan, Ashwini, Hussain, Syed Arshad

    Published in ACS omega (09-01-2024)
    “…Biocompatibility and transient nature of electronic devices have been the matter of attention in recent times due to their immense potential for sustainable…”
    Get full text
    Journal Article
  6. 6

    Drosophila Myc, a novel modifier suppresses the poly(Q) toxicity by modulating the level of CREB binding protein and histone acetylation by Singh, M. Dhruba, Raj, Kritika, Sarkar, Surajit

    Published in Neurobiology of disease (01-03-2014)
    “…Abstract Polyglutamine or poly(Q) disorders are dominantly inherited neurodegenerative diseases characterised by progressive loss of neurons in cerebellum,…”
    Get full text
    Journal Article
  7. 7

    Financial analysis for custom hire business of mechanical rice transplanter in Bangladesh by Surajit Sarkar, Md. Samiul Basir, Muhammad Ashik E Rabbani, Md. Mosharraf Hossain, Md. Monjurul Alam

    Published in Fundamental and Applied Agriculture (01-03-2020)
    “…This study was conducted to analyze the financial parameters of a mechanical rice transplanter operation for local service providers and entrepreneurs with…”
    Get full text
    Journal Article
  8. 8

    Myc functions downstream of InR and their concurrent upregulation additively restricts pathogenesis of human poly(Q) disorders in Drosophila disease models by Tandon, Shweta, Sarkar, Surajit

    “…Human polyglutamine [poly(Q)] disorders are caused by abnormal expansion of CAG repeats in one gene (disease specific), yet a plethora of cellular pathways are…”
    Get full text
    Journal Article
  9. 9

    Glipizide ameliorates human poly(Q) mediated neurotoxicity by upregulating insulin signalling in Drosophila disease models by Tandon, Shweta, Sarkar, Surajit

    “…Increasing reports suggest insulin signalling pathway as a putative drug target against polyglutamine [poly(Q)] disorders, such as Huntington's disease (HD),…”
    Get full text
    Journal Article
  10. 10

    Targeted upregulation of dMyc restricts JNK-mediated degeneration of dopaminergic neurons in the paraquat-induced Parkinson’s disease model of Drosophila by Pragati, Sarkar, Surajit

    Published in Neuroscience research (01-03-2024)
    “…Parkinson’s disease is the second most common neurodegenerative disease characterized by the loss of dopaminergic neurons in the brain. Parkinson’s disease has…”
    Get full text
    Journal Article
  11. 11

    The S6k/4E-BP mediated growth promoting sub-pathway of insulin signalling cascade is essential to restrict pathogenesis of poly(Q) disorders in Drosophila by Tandon, Shweta, Sarkar, Surajit

    Published in Life sciences (1973) (15-06-2021)
    “…Human neurodegenerative polyglutamine [poly(Q)] disorders, such as Huntington's disease (HD) and spinocerebellar ataxias (SCA), are characterised by an…”
    Get full text
    Journal Article
  12. 12

    Glutamine stimulates the S6K/4E-BP branch of insulin signalling pathway to mitigate human poly(Q) disorders in Drosophila disease models by Tandon, Shweta, Sarkar, Surajit

    Published in Nutritional neuroscience (02-07-2024)
    “…Since, the S6K/4E-BP sub-pathway can be stimulated by various amino acids; we extended our investigation to examine if oral feeding of amino acids delivers…”
    Get full text
    Journal Article
  13. 13

    Downregulation of glob1 suppresses pathogenesis of human neuronal tauopathies in Drosophila by regulating tau phosphorylation and ROS generation by Nisha, Sarkar, Surajit

    Published in Neurochemistry international (01-06-2021)
    “…Human tauopathies represent a group of neurodegenerative disorders, characterized by abnormal hyperphosphorylation and aggregation of tau protein, which…”
    Get full text
    Journal Article
  14. 14

    Age dependent trans-cellular propagation of human tau aggregates in Drosophila disease models by Aqsa, Sarkar, Surajit

    Published in Brain research (15-01-2021)
    “…•Human tau aggregates migrate trans-cellularly in aging adult Drosophila.•Tau hyperphosphorylation appears to be an important factor for trans-cellular…”
    Get full text
    Journal Article
  15. 15

    Reinstated Activity of Human Tau-induced Enhanced Insulin Signaling Restricts Disease Pathogenesis by Regulating the Functioning of Kinases/Phosphatases and Tau Hyperphosphorylation in Drosophila by Pragati, Sarkar, Surajit

    Published in Molecular neurobiology (01-02-2024)
    “…Tauopathies such as Alzheimer’s disease (AD), Frontotemporal dementia, and parkinsonism linked to chromosome 17 (FTDP-17), etc. are characterized by tau…”
    Get full text
    Journal Article
  16. 16

    Neurofibrillary tangles mediated human neuronal tauopathies: insights from fly models by Sarkar, Surajit

    Published in Journal of genetics (01-07-2018)
    “…Tauopathies represent a group of neurodegenerative disorder which are characterized by the presence of tau positive specialized argyrophilic and insoluble…”
    Get full text
    Journal Article
  17. 17

    Shaggy functions downstream of dMyc and their concurrent downregulation confers additive rescue against tau toxicity in Drosophila by Pragati, Sarkar, Surajit

    Published in BioFactors (Oxford) (01-05-2021)
    “…Neurodegenerative tauopathies such as Alzheimer's and Parkinson's diseases are characterized by hyperphosphorylation of tau protein and their subsequent…”
    Get full text
    Journal Article
  18. 18

    Downregulation of glob1 mitigates human tau mediated neurotoxicity by restricting heterochromatin loss and elevating the autophagic response in drosophila by Nisha, Sarkar, Surajit

    Published in Molecular biology reports (01-07-2022)
    “…Background Human neuronal tauopathies are typically characterized by the accumulation of hyperphosphorylated tau in the forms of paired helical filaments…”
    Get full text
    Journal Article
  19. 19

    Polyglutamine disorders: Pathogenesis and potential drug interventions by Tandon, Shweta, Aggarwal, Prerna, Sarkar, Surajit

    Published in Life sciences (1973) (01-05-2024)
    “…Polyglutamine/poly(Q) diseases are a group nine hereditary neurodegenerative disorders caused due to abnormally expanded stretches of CAG trinucleotide in…”
    Get full text
    Journal Article
  20. 20

    A Solar Flare Simulation Wheel for the Radiation Test Beamline at the Francis H. BurrProton Therapy Center by Cascio, E.W., Sarkar, S.

    Published in IEEE transactions on nuclear science (01-12-2008)
    “…The design, construction and testing of a rotating energy shifter that simulates the proton energy spectrum of a solar flare event is described…”
    Get full text
    Journal Article